Vandria logo

Vandria

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$20.6M


Vandria is a biotechnology company developing small molecule mitophagy inducers to treat age-related and chronic diseases.

Total Funding

$20.6M

Headquarters

N/A

Founded

N/A

Focus Areas

mitochondrial therapeutics
small molecule
mitophagy inducers
age-related diseases
chronic diseases
clinical trials

Investors

ND Capital logo